Table 4.
% | OR | 95% CI | |
---|---|---|---|
Total | |||
< 6.0 months | 16.2 | 1 | |
≥ 6.0 months | 30.6 | 2.28 | 1.01–5.19 |
≥ 12.0 months | 37.0 | 2.47 | 0.99–6.15 |
Perianal disease | |||
< 6.0 months | 8.1 | 1 | |
≥ 6.0 months | 24.2 | 1.93 | 0.65–5.75 |
≥ 12.0 months | 18.5 | 2.25 | 0.70–7.24 |
Abscesses, fistulas, strictures, surgery | |||
< 6.0 months | 2.7 | 1 | |
≥ 6.0 months | 8.1 | 3.16 | 0.59–16.90 |
≥ 12.0 months | 11.1 | 3.28 | 0.69–15.60 |
Co-morbidity1 | |||
< 6.0 months | 5.4 | 1 | |
≥ 6.0 months | 12.9 | 2.59 | 0.74–9.06 |
≥ 12.0 months | 11.1 | 1.35 | 0.35–5.52 |
Bolded values are statistically significant
1Autoimmune hepatitis, primary sclerosing cholangitis, uveitis, pancreatitis, venous thromboembolism, ankylosing spondylitis, peripheral arthritis, pyoderma gangrenosum, gastrointestinal malignancy. OR odds ratio, CI confidence interval